Berger Financial Group’s Labcorp LH Stock Holding History

Berger Financial Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-19,667	Closed	-$4.46M	–	267
2022 Q1	$4.46M	Buy	+19,667	New	+$4.63M	0.57%	54

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Berger Financial Group's LH Position: Q2 2022 in Review

Berger Financial Group sold out of Labcorp (LH) in Q2 2022, closing a stake of 19,667 shares — an estimated $4.46M sold.

Berger Financial Group first reported a position in LH in Q1 2022 and held it in 1 quarter. The position peaked at $4.46M in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

Berger Financial Group reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
Berger Financial Group sold 19,667 Labcorp shares in Q2 2022, an estimated $4.46M.
Berger Financial Group first reported a position in Labcorp in Q1 2022 and held it in 1 quarter.
Berger Financial Group's Labcorp position peaked at $4.46M in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Berger Financial Group's 13F filing for Q2 2022, filed 8 Aug 2022.